CHEMBL1435

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:color white (solid)
gptkbp:contraindication asthma
heart block
severe bradycardia
gptkbp:drugClass beta blocker
beta-adrenergic antagonist
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion renal
gptkbp:hasHydrogenBondAcceptorCount 4
gptkbp:hasHydrogenBondDonorCount 3
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:haspKa 9.6
gptkbp:hasReceptorAffinity selective for beta-1 adrenergic receptor
gptkbp:hasRotatableBonds 7
gptkbp:hasSMILES CC(C)NCC(COC1=CC=CC=C1OCC(=O)N)O
gptkbp:hasTPSA 74.25 Ų
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL1435
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
gptkbp:legalStatus prescription only
off-patent
gptkbp:manufacturer gptkb:AstraZeneca
gptkbp:meltingPoint 152-155°C
gptkbp:MeSH_ID gptkb:D010559
gptkbp:metabolism liver
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:originatedIn synthetic
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID 2162
CHEBI:2269
DB00335
gptkbp:routeOfAdministration oral
gptkbp:sideEffect fatigue
bradycardia
cold extremities
gptkbp:solubility water soluble
gptkbp:status approved
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
gptkbp:therapeuticArea cardiovascular system
gptkbp:bfsParent gptkb:Valacyclovir
gptkbp:bfsLayer 7